Search

Scott David Priebe

Examiner (ID: 14721)

Most Active Art Unit
1632
Art Unit(s)
1633, 1819, 1805, 1632
Total Applications
686
Issued Applications
323
Pending Applications
150
Abandoned Applications
212

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5834738 [patent_doc_number] => 20060246569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Packaging systems for human recombinant adenovirus to be used in gene therapy' [patent_app_type] => utility [patent_app_number] => 11/485114 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16404 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246569.pdf [firstpage_image] =>[orig_patent_app_number] => 11485114 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/485114
Packaging systems for human recombinant adenovirus to be used in gene therapy Jul 11, 2006 Abandoned
Array ( [id] => 5621492 [patent_doc_number] => 20060191027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/327847 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32446 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20060191027.pdf [firstpage_image] =>[orig_patent_app_number] => 11327847 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/327847
Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof Jan 5, 2006 Abandoned
Array ( [id] => 5053117 [patent_doc_number] => 20070033662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'GLP-2 receptor gene promoter and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/299663 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13649 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20070033662.pdf [firstpage_image] =>[orig_patent_app_number] => 11299663 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/299663
GLP-2 receptor gene promoter and uses thereof Dec 12, 2005 Abandoned
Array ( [id] => 5881615 [patent_doc_number] => 20060030698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Nucleic acid molecules and other molecules associated with plants' [patent_app_type] => utility [patent_app_number] => 11/256614 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23129 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030698.pdf [firstpage_image] =>[orig_patent_app_number] => 11256614 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/256614
Nucleic acid molecules and other molecules associated with plants Oct 23, 2005 Abandoned
Array ( [id] => 884572 [patent_doc_number] => 07351697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Tumor-specific vector for gene therapy' [patent_app_type] => utility [patent_app_number] => 11/186055 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4531 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351697.pdf [firstpage_image] =>[orig_patent_app_number] => 11186055 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/186055
Tumor-specific vector for gene therapy Jul 20, 2005 Issued
Array ( [id] => 6926482 [patent_doc_number] => 20050239738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Genetic inhibition of epidermal growth factor receptor function and carcinoma cell radiosensitization' [patent_app_type] => utility [patent_app_number] => 11/147349 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 21245 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239738.pdf [firstpage_image] =>[orig_patent_app_number] => 11147349 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/147349
Genetic inhibition of epidermal growth factor receptor function and carcinoma cell radiosensitization Jun 7, 2005 Abandoned
Array ( [id] => 5882873 [patent_doc_number] => 20060031956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Nucleotide sequences for gene regulation and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/129861 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 28664 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20060031956.pdf [firstpage_image] =>[orig_patent_app_number] => 11129861 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/129861
Nucleotide sequences for gene regulation and methods of use thereof May 15, 2005 Issued
11/124617 Novel mutated mammalian cells and animals May 5, 2005 Abandoned
Array ( [id] => 5766742 [patent_doc_number] => 20060018888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Suicidal mutant leishmania vaccine' [patent_app_type] => utility [patent_app_number] => 11/091882 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18114 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018888.pdf [firstpage_image] =>[orig_patent_app_number] => 11091882 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/091882
Suicidal mutant Leishmania vaccine Mar 27, 2005 Issued
Array ( [id] => 484639 [patent_doc_number] => 07217411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-15 [patent_title] => 'CeSERT genes, proteins, and modulatory compounds' [patent_app_type] => utility [patent_app_number] => 11/033003 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 27 [patent_no_of_words] => 19130 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217411.pdf [firstpage_image] =>[orig_patent_app_number] => 11033003 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/033003
CeSERT genes, proteins, and modulatory compounds Jan 10, 2005 Issued
Array ( [id] => 6938540 [patent_doc_number] => 20050112103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Methods and compositions for the treatment of defects in lipoprotein metabolism' [patent_app_type] => utility [patent_app_number] => 11/029942 [patent_app_country] => US [patent_app_date] => 2005-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16488 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112103.pdf [firstpage_image] =>[orig_patent_app_number] => 11029942 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/029942
Methods and compositions for the treatment of defects in lipoprotein metabolism Jan 4, 2005 Issued
Array ( [id] => 5882864 [patent_doc_number] => 20060031947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Novel mutated mammalian cells and animals' [patent_app_type] => utility [patent_app_number] => 11/021492 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 5496 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20060031947.pdf [firstpage_image] =>[orig_patent_app_number] => 11021492 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/021492
Novel mutated mammalian cells and animals Dec 22, 2004 Abandoned
Array ( [id] => 820471 [patent_doc_number] => 07407801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Truncated CMV promoters and vectors containing same' [patent_app_type] => utility [patent_app_number] => 11/005410 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 11 [patent_no_of_words] => 7526 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407801.pdf [firstpage_image] =>[orig_patent_app_number] => 11005410 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/005410
Truncated CMV promoters and vectors containing same Dec 5, 2004 Issued
Array ( [id] => 6944723 [patent_doc_number] => 20050196772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation' [patent_app_type] => utility [patent_app_number] => 10/978758 [patent_app_country] => US [patent_app_date] => 2004-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17212 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196772.pdf [firstpage_image] =>[orig_patent_app_number] => 10978758 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/978758
Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation Oct 31, 2004 Abandoned
Array ( [id] => 6983245 [patent_doc_number] => 20050153315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Dimethylarginine dimethylaminohydrolases' [patent_app_type] => utility [patent_app_number] => 10/966039 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13563 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153315.pdf [firstpage_image] =>[orig_patent_app_number] => 10966039 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/966039
Dimethylarginine dimethylaminohydrolases Oct 17, 2004 Abandoned
Array ( [id] => 435632 [patent_doc_number] => 07261886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Insect larva aerosol infection method for producing recombinant proteins and baculovirus bio-insecticides' [patent_app_type] => utility [patent_app_number] => 10/945898 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2598 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/261/07261886.pdf [firstpage_image] =>[orig_patent_app_number] => 10945898 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/945898
Insect larva aerosol infection method for producing recombinant proteins and baculovirus bio-insecticides Sep 21, 2004 Issued
Array ( [id] => 893956 [patent_doc_number] => 07341710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Method of identifying molecules that home to a selected organ in vivo' [patent_app_type] => utility [patent_app_number] => 10/943372 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11312 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/341/07341710.pdf [firstpage_image] =>[orig_patent_app_number] => 10943372 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/943372
Method of identifying molecules that home to a selected organ in vivo Sep 16, 2004 Issued
Array ( [id] => 7252420 [patent_doc_number] => 20040259208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Liver specific transcriptional enhancer' [patent_app_type] => new [patent_app_number] => 10/885457 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14085 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259208.pdf [firstpage_image] =>[orig_patent_app_number] => 10885457 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/885457
Liver specific transcriptional enhancer Jul 5, 2004 Issued
Array ( [id] => 7177902 [patent_doc_number] => 20050123942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Novel sphingosine kinases' [patent_app_type] => utility [patent_app_number] => 10/876281 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 34672 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123942.pdf [firstpage_image] =>[orig_patent_app_number] => 10876281 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/876281
Novel sphingosine kinases Jun 23, 2004 Abandoned
Array ( [id] => 7107893 [patent_doc_number] => 20050108779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Transgenic flies expressing Abeta42-Italian' [patent_app_type] => utility [patent_app_number] => 10/852974 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14009 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20050108779.pdf [firstpage_image] =>[orig_patent_app_number] => 10852974 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/852974
Transgenic flies expressing Abeta42-Italian May 24, 2004 Abandoned
Menu